Windlas Biotech Limited (NSE:WINDLAS) — Stock Price
Windlas Biotech Limited (NSE:WINDLAS) is currently trading at Rs839.65 INR, down 4.89% today. Over the past 52 weeks, shares have ranged between Rs718.35 and Rs1070.80. This page tracks Windlas Biotech Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Windlas Biotech Limited (WINDLAS) market capitalisation.
Windlas Biotech Limited (WINDLAS) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Windlas Biotech Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Windlas Biotech Limited Income Statement — Revenue, Profit & Earnings by Year
Windlas Biotech Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Rs7.60 Billion | Rs6.29 Billion | Rs5.11 Billion | Rs4.63 Billion | Rs4.27 Billion |
| Cost of Revenue | Rs4.72 Billion | Rs4.00 Billion | Rs3.30 Billion | Rs3.03 Billion | Rs2.74 Billion |
| Gross Profit | Rs2.88 Billion | Rs2.28 Billion | Rs1.81 Billion | Rs1.61 Billion | Rs1.52 Billion |
| Research & Development | Rs62.51 Million | Rs78.77 Million | Rs89.48 Million | Rs65.11 Million | Rs36.06 Million |
| SG&A | Rs31.82 Million | Rs37.35 Million | Rs40.12 Million | Rs47.69 Million | Rs35.50 Million |
| Total Operating Expenses | Rs2.22 Billion | Rs486.95 Million | Rs400.81 Million | Rs1.20 Billion | Rs227.95 Million |
| Operating Income | Rs661.22 Million | Rs652.21 Million | Rs479.24 Million | Rs402.76 Million | Rs434.14 Million |
| EBITDA | Rs1.12 Billion | Rs916.40 Million | Rs701.91 Million | Rs591.29 Million | Rs361.68 Million |
| EBIT | Rs841.40 Million | Rs781.96 Million | Rs578.27 Million | Rs469.82 Million | Rs232.03 Million |
| Interest Expense | Rs43.82 Million | Rs11.05 Million | Rs7.88 Million | Rs14.17 Million | Rs12.90 Million |
| Income Before Tax | Rs797.58 Million | Rs770.91 Million | Rs570.39 Million | Rs455.65 Million | Rs217.40 Million |
| Income Tax Expense | Rs187.64 Million | Rs189.04 Million | Rs144.13 Million | Rs74.76 Million | Rs61.70 Million |
| Net Income | Rs609.94 Million | Rs581.87 Million | Rs426.26 Million | Rs380.89 Million | Rs158.32 Million |
Windlas Biotech Limited Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Windlas Biotech Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Rs7.60 Billion | Rs6.26 Billion | Rs5.29 Billion | Rs4.91 Billion | Rs2.96 Billion |
| Total Current Assets | Rs5.25 Billion | Rs4.31 Billion | Rs3.54 Billion | Rs3.82 Billion | Rs1.94 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | Rs2.40 Billion | Rs1.99 Billion | Rs1.28 Billion | Rs1.75 Billion | Rs383.25 Million |
| Net Receivables | Rs1.67 Billion | Rs1.37 Billion | Rs1.17 Billion | Rs1.11 Billion | Rs794.13 Million |
| Inventory | Rs813.84 Million | Rs621.89 Million | Rs747.38 Million | Rs587.10 Million | Rs414.61 Million |
| Property, Plant & Equipment | — | — | — | Rs983.15 Million | Rs954.95 Million |
| Goodwill | — | — | — | Rs0.00 | Rs0.00 |
| Total Liabilities | Rs2.55 Billion | Rs1.76 Billion | Rs1.27 Billion | Rs962.33 Million | Rs970.04 Million |
| Total Current Liabilities | Rs2.49 Billion | Rs1.72 Billion | Rs1.21 Billion | Rs939.86 Million | Rs934.19 Million |
| Long-term Debt | Rs0.00 | Rs0.00 | Rs1.09 Million | Rs4.40 Million | Rs8.32 Million |
| Net Debt | Rs321.73 Million | Rs-16.47 Million | Rs13.07 Million | Rs60.67 Million | Rs164.19 Million |
| Total Stockholder Equity | Rs5.06 Billion | Rs4.50 Billion | Rs4.02 Billion | Rs3.95 Billion | Rs1.99 Billion |
| Retained Earnings | Rs2.75 Billion | Rs2.26 Billion | Rs1.76 Billion | Rs1.42 Billion | Rs1.04 Billion |
Windlas Biotech Limited Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Windlas Biotech Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rs681.87 Million | Rs1.09 Billion | Rs609.65 Million | Rs91.30 Million | Rs114.54 Million |
| Capital Expenditures | Rs521.94 Million | Rs376.84 Million | Rs708.90 Million | Rs148.04 Million | Rs58.47 Million |
| Free Cash Flow | Rs159.93 Million | Rs712.76 Million | Rs-99.25 Million | Rs-56.74 Million | Rs56.07 Million |
| Investing Cash Flow | Rs-740.64 Million | Rs-920.68 Million | Rs-141.10 Million | Rs-1.55 Billion | Rs-201.98 Million |
| Financing Cash Flow | Rs10.13 Million | Rs-152.90 Million | Rs-437.39 Million | Rs1.30 Billion | Rs7.76 Million |
| Dividends Paid | Rs114.95 Million | Rs83.01 Million | Rs76.28 Million | Rs76.28 Million | — |
| Stock-Based Compensation | Rs24.60 Million | Rs20.67 Million | Rs10.08 Million | Rs18.13 Million | Rs18.13 Million |
| Depreciation | Rs279.85 Million | Rs134.44 Million | Rs123.64 Million | Rs121.47 Million | Rs129.65 Million |
| Change in Cash | Rs-48.64 Million | Rs16.02 Million | Rs31.16 Million | Rs-153.60 Million | Rs-21.48 Million |
Windlas Biotech Limited Earnings History — EPS Actual vs. Analyst Estimates
Track Windlas Biotech Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for Windlas Biotech Limited.